Beyond Air Reports Financial Results for the Third Quarter of Fiscal Year 2023
09.02.2023 - U.S. commercial launch continues for LungFit PH for the treatment of term and near-term neonates with hypoxic respiratory failure Presented positive in vivo combination data with anti-PD1 that support the potential of the Company’s novel gaseous ...
Source: wallstreet-online.de